# LOGISTICAL AND IT SUPPORT FOR THE NCI CENTRAL INDIVIDUAL REVIEW BOARD (CIRB)

> **NIH NIH N02** · THE EMMES COMPANY, LLC · 2024 · $9,054,450

## Abstract

The NCI Central Institutional Review Board is dedicated to protecting the rights and welfare of participants in cancer clinical trials. Institutions across the country rely on the CIRB national experts to ensure that clinical trials are reviewed efficiently and with the highest ethical and quality standards.  The NCI CIRB helps reduce the administrative burden on local IRBs and investigators while continuing a high level of protection for human research participants. CIRB, with one centralized review, enables investigators to enroll patients into Network trials significantly faster than when employing the traditional method of assessment, which requires trial investigators in each site to obtain approval from a local IRB.

## Key facts

- **NIH application ID:** 11212016
- **Project number:** 75N91024C00024-0-9999-1
- **Recipient organization:** THE EMMES COMPANY, LLC
- **Principal Investigator:** CLAUDINE VALMONTE
- **Activity code:** N02 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $9,054,450
- **Award type:** —
- **Project period:** 2024-09-01 → 2025-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11212016

## Citation

> US National Institutes of Health, RePORTER application 11212016, LOGISTICAL AND IT SUPPORT FOR THE NCI CENTRAL INDIVIDUAL REVIEW BOARD (CIRB) (75N91024C00024-0-9999-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/11212016. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*